Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Krabatsch, T; Schweiger, M; Stepanenko, A; Drews, T; Potapov, E; Vierecke, J; Jurmann, B; Pasic, M; Weng, YG; Huebler, M; Hetzer, R.
Technical possibilities and limitations of mechanical circulatory support.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2011; 46(6):414-421
Doi: 10.1055/s-0031-1280746
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Schweiger Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Ventricular assist devices (VAD) to support the left (LVAD), the right (RVAD) or both ventricles (BVAD) have emerged as one standard of care for advanced heart failure patients. Initially used to bridge patients to transplantation (BTT) they are now more frequently implanted as permanent support (destination therapy, DT). Bridge to recovery (BTR) is a valid option for only a small number of patients. Although there are different devices available, patient selection, preoperative and intraoperative management, and the timing of VAD implantation are the elements critical to successful circulatory support.
- Find related publications in this database (using NLM MeSH Indexing)
-
Anticoagulants - therapeutic use
-
Assisted Circulation - adverse effects
-
Echocardiography, Transesophageal -
-
Heart Failure - surgery
-
Heart Transplantation -
-
Heart Ventricles -
-
Heart-Assist Devices - adverse effects
-
Humans -
-
Intraoperative Care -
-
Patient Selection -
-
Recovery of Function -
-
Thrombosis - therapy